Free Trial

Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Martingale Asset Management L P

Addus HomeCare logo with Medical background
Remove Ads

Martingale Asset Management L P lessened its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 30.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 19,112 shares of the company's stock after selling 8,269 shares during the period. Martingale Asset Management L P owned approximately 0.11% of Addus HomeCare worth $2,396,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Quarry LP purchased a new stake in Addus HomeCare in the 3rd quarter valued at approximately $28,000. Smartleaf Asset Management LLC lifted its holdings in Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after acquiring an additional 214 shares during the period. Parkside Financial Bank & Trust boosted its position in shares of Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after purchasing an additional 148 shares in the last quarter. Meeder Asset Management Inc. acquired a new position in shares of Addus HomeCare during the 4th quarter worth $77,000. Finally, Harvest Fund Management Co. Ltd purchased a new position in shares of Addus HomeCare in the 4th quarter valued at about $86,000. Hedge funds and other institutional investors own 95.35% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on ADUS shares. Stephens reissued an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. StockNews.com lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Macquarie reiterated an "outperform" rating and set a $129.00 price target on shares of Addus HomeCare in a report on Thursday, February 27th. Oppenheimer upped their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Finally, Citizens Jmp raised shares of Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Addus HomeCare currently has a consensus rating of "Moderate Buy" and an average target price of $132.78.

Remove Ads

View Our Latest Analysis on ADUS

Addus HomeCare Stock Down 3.0 %

Shares of Addus HomeCare stock traded down $3.05 during trading hours on Tuesday, hitting $99.13. The company's stock had a trading volume of 135,421 shares, compared to its average volume of 163,669. The business has a fifty day moving average of $100.73 and a 200 day moving average of $117.77. Addus HomeCare Co. has a 1-year low of $87.88 and a 1-year high of $136.72. The company has a market capitalization of $1.80 billion, a PE ratio of 22.68, a P/E/G ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. On average, sell-side analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads